ICO
Closing Date:

Novel Small Molecules targeting RNA, RNA-binding Proteins, or RNA-modifying Proteins, for Use in Oncology, Neuroscience, and Inflammation

NextRNA Therapeutics, a biotechnology company developing small molecule therapeutics targeting long non-coding RNAs and RNA-binding proteins is seeking novel small molecules that target RNA, RNA-binding proteins or RNA-modifying proteins for treating diseases in oncology, neuroscience, and inflammation.

In Scope:

  • Ideally genetically driven disease mechanisms
  • RNA targets can be long non-coding RNAs, non-coding RNAs (e.g. microRNAs), or messenger RNAs. Protein targets can be RNA-binding proteins, RNA-modifying proteins, or DNA-binding proteins (e.g. Transcription...

Opportunity types being sought:

  • Biotech Asset

To see the full details and submit your response please register now.

Benefits of registration:

  • Receive updates on the latest industry calls
  • Quickly and easily respond to calls via your dashboard
  • Build your academic profile

Opportunity types being sought:

  • Biotech Asset

An online matchmaking platform for university-industry collaboration. Learn More

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.